{"id":"W2162070501","doi":"10.1016/s2213-2600(14)70218-8","title":"Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)","year":2014,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Institute for Health and Care Research; Vertex Pharmaceuticals","keywords":"Ivacaftor; Medicine; Cystic fibrosis; Adverse effect; Cystic fibrosis transmembrane conductance regulator; Internal medicine; Placebo; Exacerbation; Clinical trial; Vital capacity; Pediatrics; Lung; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002161253,0.0002823614,0.001010288,0.0001525075,0.0002090665,0.00002996372,0.0005357094,0.00005652754,0.00006789141],"category_scores_gemma":[0.002409554,0.0001322384,0.00002564345,0.0004642268,0.0007964757,0.0001510093,0.0002518872,0.0004272787,0.000005303646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001002355,"about_ca_system_score_gemma":0.00009870952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008816839,"about_ca_topic_score_gemma":0.00009186946,"domain_scores_codex":[0.996846,0.0006177967,0.0006352768,0.0004862634,0.0009901256,0.0004245329],"domain_scores_gemma":[0.9966388,0.001434337,0.0002892987,0.001131179,0.0003148425,0.0001915652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08497242,0.005563379,0.8269531,0.0007456312,0.0003652635,0.0001396552,0.004132331,0.00006778623,0.004532839,0.000123102,0.003516095,0.06888841],"study_design_scores_gemma":[0.0722212,0.01696325,0.9067476,0.001382828,0.0002238373,0.00001125049,0.0004611614,0.0002700883,0.0001189471,0.00001891291,0.001433987,0.0001468618],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932651,0.00130566,0.0003389549,0.001635536,0.00004350492,0.00298662,0.00001812942,0.00002418691,0.0003823031],"genre_scores_gemma":[0.9984134,0.00002884283,0.0001558661,0.0007952409,0.0003628641,0.00006726453,0.00002713865,0.00003536703,0.0001140068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07979458,"threshold_uncertainty_score":0.5392525,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0512044956508712,"score_gpt":0.3703018280819421,"score_spread":0.3190973324310709,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}